Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Discovery & Translation

Causal biology in the age of big data

Where do you start? Patient data might sound more obvious, but human cell-based models have advantages

October 7, 2024 9:35 PM UTC

Expectations are rising for researchers to show newly proposed drug targets have a causal role in driving or preventing disease. Companies mining human data to uncover novel target biology are all drawing on multiple lines of evidence, but they differ in where they start and what they emphasize — decisions that dictate their data needs and a host of other practical considerations.

The mandate to provide proof of causal human biology for novel targets, which was the subject of BioCentury’s 32nd annual Back to School edition in September, has emerged from the growing availability of human -omics data and increasingly sophisticated tools for measurement and analysis. ...

Get Unlimited Access
To view this item, login or register for a free account.
Or Purchase This Article